Ascentage Pharma corrects timing for August 19 interim results release
The company revised the start time of its six-month 2026 results webcast to 7:00 am EDT after an earlier release listed 9:00 am EDT in error.
Ascentage Pharma Group International issued a correction on August 5, 2026 to a press release originally issued the same day. The earlier release had stated the timing incorrectly, and the company clarified that the correct time is 7:00 am Eastern Daylight Time on August 19, 2026, or 7:00 pm Hong Kong Time, rather than 9:00 am EDT and 9:00 pm HKT as previously stated.1
The corrected release confirms that Ascentage Pharma will release its unaudited six months 2026 interim results and provide business updates at that revised time on August 19, 2026.1 Analysts and investors are invited to join an investor webcast with a question and answer session led by company management.1
Separate investor calls are also planned around the same period. A Mandarin-language investor webcast is scheduled for 9:00 pm EDT on August 19, 2026, corresponding to 9:00 am Hong Kong time on August 20, 2026.1 A separate English-language conference call and webcast is set for 8:00 am EDT, which corresponds to 8:00 pm Hong Kong time, on August 20, 2026.1 A replay of the English-language call and presentation will later be posted to the company's website.1
The filing also notes other recent disclosures. On August 13, 2026, Ascentage Pharma issued English- and Chinese-language releases announcing participation in the Evercore 2nd Annual China Biotech Summit.1
Written by readthrough’s AI from the linked primary sources and fact-checked against them automatically before publishing. Not investment advice.